Skip to main navigation
logo

SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
REGDEX
Filing Date
Jul 3, 2002
Document Date
Jul 3, 2002
Form Description
REGDEX
Filing Group
Other
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Print Page
RSS Feeds
E-Mail Alerts
Contact IR
Investor Relations
  • Home
  • Press Releases
  • Corporate Governance
    • Highlights
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Events & Presentations
  • Financial Information
    • Financial Overview
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor Contact
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Strategic Collaborations
    • Contact
  • Our Programs
    • Pipeline
    • Bemarituzumab
    • FPT155
    • TIM-3
    • Clinical Trials
    • Expanded Access
  • Publications
  • Join Our Team
    • Culture
    • Careers
  • Investors & Media
    • Press Releases
    • Corporate Governance
      • Highlights
      • Management
      • Board Of Directors
      • Committee Composition
      • Contact The Board
    • Events & Presentations
    • Financial Information
      • Financial Overview
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor Contact
  • News
  • Publications
  • Contact
  • LinkedIn
  • Twitter
  • Home
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Strategic Collaborations
    • Contact
  • Our Programs
    • Pipeline
    • Bemarituzumab
    • FPT155
    • TIM-3
    • Clinical Trials
    • Expanded Access
  • Publications
  • Join Our Team
    • Culture
    • Careers
  • Investors & Media
    • Press Releases
    • Corporate Governance
      • Highlights
      • Management
      • Board Of Directors
      • Committee Composition
      • Contact The Board
    • Events & Presentations
    • Financial Information
      • Financial Overview
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor Contact
    • News
    • Publications
    • Contact
    • Linkedin
    • Twitter
    • Legal Notice
    • Privacy Policy

logo

© 2021 Five Prime Therapeutics, Inc. All rights reserved
  • Legal Notice
  • Privacy Policy
Website Design: Hane Chow, Inc.